| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | 0.53 | 0.2 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | 0.5 | 0.08 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.49 | 2e-36 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | 0.47 | 0.05 |
| mRNA | Imatinib | FIMM | pan-cancer | AAC | 0.47 | 0.09 |
| mRNA | ABT-263 | FIMM | pan-cancer | AAC | 0.46 | 0.04 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.44 | 8e-15 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | 0.4 | 7e-14 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | 0.39 | 0.2 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | 0.37 | 0.2 |